First Header Logo Second Header Logo

Connection

Mark Chappell to F2-Isoprostanes

Back to Details
This is a "connection" page, showing publications Mark Chappell has written about F2-Isoprostanes.
Mark Chappell
Connection Strength
0.056
F2-Isoprostanes
  1. Chappell MC, Gallagher PE, Averill DB, Ferrario CM, Brosnihan KB. Estrogen or the AT1 antagonist olmesartan reverses the development of profound hypertension in the congenic mRen2. Lewis rat. Hypertension. 2003 Oct; 42(4):781-6.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.